Narcolepsy in prepubertal children

Annals of Neurology
C Guilleminault, R Pelayo

Abstract

Narcolepsy was diagnosed in 51 children (29 boys). The age range was 2.1 to 11.8 years (mean, 7.9 +/- 3.1 years). A mean of three referrals was made before narcolepsy was considered. In 10 children, cataplexy was the presenting symptom. Thirty-eight children acknowledged sleep paralysis and 30 acknowledged hypnagogic hallucinations. All children had sleep studies; 31 exhibited rapid eye movement at sleep onset. The mean sleep latency was 1.5 minutes +/- 39 seconds on the Multiple Sleep Latency Test. All children had at least two sleep-onset rapid eye movement sleep episodes in this test. Forty-six children were HLA class II-positive for DQw6, and 45 were also positive for DRw15. Thirty (65%) families refused referrals to support and counseling groups. Teachers often refused to acknowledge a medical problem. During follow-up, all children presented at least once with depressive symptoms in reaction to their syndrome. Narcolepsy should be considered when evaluating children with behavioral and depressive symptoms.

References

Apr 25, 1992·Lancet·D J Nokes, R M Anderson
Dec 9, 1989·Lancet·C GuilleminaultF C Grumet
Mar 1, 1996·Seminars in Pediatric Neurology·S Kotagal

❮ Previous
Next ❯

Citations

Mar 20, 2002·Current Neurology and Neuroscience Reports·Phillip L Pearl
Jun 7, 2005·Primary Care·Mark E Dyken, Thoru Yamada
Jan 17, 2004·Sleep Medicine·Emma MorrishJohn M Shneerson
Oct 29, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Yves DauvilliersJacques Montplaisir
Apr 15, 2009·Journal of Child and Adolescent Psychopharmacology·Lene Ruge Møller, John R Østergaard
Oct 22, 2013·Brain : a Journal of Neurology·Fabio PizzaGiuseppe Plazzi
Nov 26, 1999·Archives of Disease in Childhood·G Stores
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·N J Douglas
May 9, 2003·Pediatric Research·Louise Margaret O'BrienDavid Gozal
Jun 24, 2014·Current Neurology and Neuroscience Reports·Sona Nevsimalova
Jul 9, 2008·Developmental Neurorehabilitation·Liam DorrisIrene McArthur
Apr 17, 2008·Developmental Neurorehabilitation·Liam DorrisColin Espie
Oct 1, 2005·International Review of Psychiatry·Sharon Reutens, Perminder S Sachdev
Jul 9, 2013·Sleep Medicine·Giuseppe Plazzi, Fabio Pizza
Oct 9, 2012·Child and Adolescent Psychiatric Clinics of North America·Rafael Pelayo, Kin Yuen
Feb 25, 2011·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Sona NevsimalovaJelena Skibova
Feb 2, 2011·Pediatric Clinics of North America·Bantu ChhanganiCynthia Feucht
Nov 7, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·M Merino-Andréu, A Martínez-Bermejo
Jun 13, 2009·Pediatric Neurology·Yu-Shu Huang, Christian Guilleminault
May 9, 2009·Sleep Medicine·Sona NevsimalovaJelena Skibova
Jan 21, 2009·Sleep Medicine Reviews·Sona Nevsimalova
Apr 16, 2008·Pediatric Neurology·Martina VendrameSanjeev V Kothare
Apr 1, 2008·Brain & Development·Paul C Peterson, Aatif M Husain
Aug 30, 2008·Acta Paediatrica·Kutluhan YilmazAyse Kilincaslan
Aug 17, 2006·Acta Neurologica Scandinavica·S ErvikG Strand
Mar 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Leonardo SerraGiuseppe Plazzi
Mar 18, 2006·Developmental Medicine and Child Neurology·Gregory Stores
Mar 11, 2004·Pediatric Clinics of North America·Madeleine Grigg-Damberger
Apr 17, 2004·The Medical Clinics of North America·Merrill S Wise
Jun 15, 2015·Seminars in Pediatric Neurology·Thomas J DyeSanjeev V Kothare
Jun 15, 2015·Seminars in Pediatric Neurology·Matthew M Troester, Rafael Pelayo
Oct 18, 2008·Clinical Child Psychology and Psychiatry·Sasha Hvidsten, Gordon Bates
Apr 9, 2001·Journal of Child Neurology·S J Sharp, O F D'Cruz
Oct 31, 2002·Clinical Pediatrics·Manisha B Witmans, Valerie G Kirk
Mar 23, 2017·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Jochen GehrmannInga Reimer
Jan 24, 2019·The Journal of Nervous and Mental Disease·Alberto RaggiRaffaele Ferri
Aug 14, 2019·Neurology·Fabio PizzaUNKNOWN MonBo Study Group
Aug 11, 2000·Paediatric Drugs·C Guilleminault, R Pelayo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Child and Adolescent Psychiatry
R E DahlL Trubnick
American Journal of Diseases of Children
D YoungT Roth
Archives of Disease in Childhood
Gregory Stores
© 2021 Meta ULC. All rights reserved